Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
- 9 December 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 30 (1), 35-41
- https://doi.org/10.1016/j.vaccine.2011.10.062
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/YamagataThe Pediatric Infectious Disease Journal, 2011
- Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in EnglandThe Journal of Infectious Diseases, 2011
- Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory‐Confirmed Secondary Attack Rates and Evidence of Asymptomatic InfectionsClinical Infectious Diseases, 2010
- Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 monthsVaccine, 2010
- Protective effect of single‐dose adjuvanted pandemic influenza vaccine in childrenInfluenza and Other Respiratory Viruses, 2010
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyBMJ, 2010
- Effect of an immunization program on seasonal influenza hospitalizations in Mexican childrenVaccine, 2010
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Vaccines for Seasonal and Pandemic InfluenzaThe Journal of Infectious Diseases, 2006
- Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming?Published by American Academy of Pediatrics (AAP) ,2006